PHAT CIK: 1783183

Phathom Pharmaceuticals, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−148
FY22:
−147
FY23:
−138
FY24:
−267
FY25:
−167
Change from FY21 to FY25
millions USD
FY21:
−0.33
FY22:
−1.04
FY23:
−1.63
FY24:
−0.14
FY25:
−0.23
Change from FY21 to FY25
millions USD
FY21:
44.7
FY22:
120
FY23:
368
FY24:
183
FY25:
−0.29
millions USD
FY21:
−104
FY22:
−27.5
FY23:
228
FY24:
−84.1
FY25:
−167
(positive)
Change from FY21 to FY25
millions USD
FY21:
−149
FY22:
−148
FY23:
−139
FY24:
−267
FY25:
−167

All amounts in millions USD Data source:SEC EDGAR